Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84

Authors:
  • BGB E Gilbert
    B E Gilbert
  • SWS Z Wilson
    S Z Wilson
  • VKV Knight
    V Knight
  • RCR B Couch
    R B Couch
  • JQJ M Quarles
    J M Quarles
  • LDL Dure
    L Dure
  • NHN Hayes
    N Hayes
  • GWG Willis
    G Willis

Abstract
In a double-blind study of influenza in a population of college students in 1984, ribavirin small-particle aerosol treatment of 38 patients (18 treated, 20 control) infected with a new antigenic variant, influenza virus strain A/Victoria/7/83 (H1N1), was associated with statistically significant reductions in the height and duration of fever, systemic symptoms, and virus shedding. Patients received a total of 2.4 g of ribavirin over 42 h during 68 h of hospitalization without any side effects. In addition, in a study of patients infected with influenza virus strain B/Texas/1/84 (seven treated, eight control) treated with ribavirin aerosol showed a trend of more rapid recovery than control patients.

This publication has 7 references indexed in Scilit: